Author:
Hisano Michi,Morisaki Naho,Sampei Makiko,Obikane Erika,Yamaguchi Koushi
Funder
Japan Health Research Promotion Bureau
Reference18 articles.
1. World Health Organization (WHO). WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020, https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [accessed on 15 May 2024].
2. Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management;Anka;Scand J Immunol,2021
3. Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia;Yasmin;Immun Inflamm Dis,2023
4. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19;Zhang;N Engl J Med,2020
5. Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward;Le Joncour;Autoimmun Rev,2021